HPC on AWS for COVID-19 Research and Development

As part of the COVID-19 HPC Consortium, AWS is offering research institutions and companies technical support and promotional credits for the use of AWS services to advance research on diagnosis, treatment, and vaccine studies to accelerate our collective understanding of the novel coronavirus (COVID-19). Researchers and scientists working on time-critical projects can use AWS to instantly access virtually unlimited infrastructure capacity, and the latest technologies in compute, storage and networking to accelerate time to results.

Researchers are invited to submit COVID-19 related research proposals to the COVID-19 HPC Consortium via the online portal. Proposals are evaluated by a panel of experts and selected proposals will be matched with computing resources from one of the participating consortium members.

Quick links to additional resources to help accelerate your COVID-19 research

Registry of Open Data on AWS
When organizations make data open on AWS, scientists can access and analyze it, delivering innovative solutions to big challenges. AWS makes a variety of Public Data Sets available to researchers and the public.

Complete list of Public Datasets available in the AWS Cloud »

Genomics Resources on AWS
Access our online guides to learn how to use AWS services, such as Amazon S3, AWS Step Functions, and AWS Batch, as well as popular open source workflow orchestrators like Cromwell and Nextflow, to run large scale genomics workflows on AWS.

Quick Start Guide to deploy a genomics analysis environment on AWS using Nextflow and AWS Batch »

Genomics Workflows on AWS »

AWSLabs GitHub for genomics »

Using Amazon FSx for Lustre for genomics workflows on AWS »

Creating an AWS Batch environment for mixed CPU and GPU genomics workflows »

Improving the diagnosis of infectious diseases with microbial genomic analysis »

Building simpler genomics workflows using AWS Step Functions »

Building a scalable image processing pipeline for image-based transcriptomics »

Tracking global antimicrobial resistance among pathogens using Nextflow and AWS »

Drug Discovery and Pre-Clinical Research using AWS »

 
Contact us
Using Amazon FSx for Lustre for Genomics Workflows on AWS

More AWS initiatives helping with COVID-19 research

AWS Diagnostic Development Initiative (DDI)

The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

Start your application now >>